The evidence of the interaction between 14-3-3 proteins and the signal transducer IRS-2 in vivo opens several novel perspectives in the (patho)physiological regulation of the biological function of IRS-2 including its role in metabolic disorders such as insulin resistance and type 2 diabetes. This evidence concerns the gene YWHAQ and Other metabolic disease.